Evidence map›Paper›PMID 42176353›Full record

ArticleACS synthetic biology2026

Receptor-Guided AAV Tropism Engineering via MATCH.

Nolan Graham, Satheesh Kumar, Joseph Rainaldi, Seoin Yang, Andrew Portell, Billy Santoso, Prashant Mali

Abstract read
PubMed Publisher
In one paragraph

Article in ACS synthetic biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Nolan GrahamDepartment of Bioengineering, University of California San Diego, La Jolla, California 92093, United States.ORCID 0009-0009-4566-842X
Satheesh KumarDepartment of Bioengineering, University of California San Diego, La Jolla, California 92093, United States.
Joseph RainaldiDepartment of Bioengineering, University of California San Diego, La Jolla, California 92093, United States.
Seoin YangSchool of Biological Sciences, University of California San Diego, La Jolla, California 92093, United States.
Andrew PortellDepartment of Bioengineering, University of California San Diego, La Jolla, California 92093, United States.
Billy SantosoSchool of Biological Sciences, University of California San Diego, La Jolla, California 92093, United States.
Prashant MaliDepartment of Bioengineering, University of California San Diego, La Jolla, California 92093, United States.ORCID 0000-0002-3383-1287

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise control over viral tropism remains a major challenge in the development of gene delivery technologies. We present MATCH (Modulation of AAV Tropism through Conjugation to Homing proteins), a modular biochemical method that enables programmable, receptor-guided retargeting of adeno-associated viruses (AAVs) through site-specific covalent protein conjugation. By incorporating a SpyTag peptide motif into selected AAV capsid loops, MATCH allows one-step, stoichiometrically defined attachment of recombinant SpyCatcher-linked targeting proteins to the viral surface. Using mosaic AAV-DJ and AAV9 capsids with controlled SpyTag incorporation, we achieve efficient assembly and tunable ligand display. MATCH-AAVs conjugated to an anti-CD3 single-chain antibody efficiently activate and transduce resting human T cells within mixed PBMC populations in vitro, achieving transduction levels of up to ∼58% of the total PBMCs. Conjugation to transferrin receptor (TfR1)-binding proteins yielded enhanced brain transduction in vivo, with murine TfR1-targeted MATCH-AAV9 exhibiting up to an 88-fold increase in brain expression relative to wild-type AAV9. Human TfR1-targeted vectors similarly enabled robust, receptor-dependent transduction both in vitro and in humanized mouse models. Both TfR1-targeted vectors enabled widespread transduction of the parenchyma, consistent with TfR1-mediated crossing of the blood-brain barrier. Finally, we establish a streamlined one-pot "Mix-and-MATCH" production strategy in which capsid and targeting ligands are coexpressed during vector generation, yielding functional, targeted AAVs at titers comparable to conventional production. This simple and generalizable synthetic-biology approach provides a versatile toolkit for rational AAV tropism engineering, offering a scalable route to custom vector design for research and therapeutic applications.

Indexed as

DependovirusReceptors, TransferrinViral TropismAnimalsCapsidCapsid ProteinsGenetic VectorsGene Transfer TechniquesHumansMiceTransduction, GeneticCapsid ProteinsReceptors, TransferrinAAV capsid engineeringblood−brain barrierimmune cell engineeringSpyTag/SpyCatchertargeted gene deliverytransferrin receptor (TfR1)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.